Cardio-oncology & other

Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study

Eur Heart JPublished Retrospective cohort study

Authors' conclusion

These findings suggest that live zoster vaccination may be beneficial as a public health strategy with potential implications for cardiovascular disease burden in the general population.

Study context

Population
Individuals aged ≥50 years in South Korea, 2012–20211,271,922 overlap-weighted
Participants
2,207,784 individuals
Exposure
Live zoster vaccination vs no vaccination
Outcome
Risk of CVD by International Classification of Diseases, Tenth Revision code diagnosis
Methodological detailsnationwide, population-based, propensity score-based overlap weighting
  • Nationwide
  • Population-based
  • Propensity score-based overlap weighting

Main finding

As reported in the abstract

Overall CV events
Each group vs unvaccinatedHazard ratio (95% CI)
Vaccinated
0.77(0.76–0.78)
Each group vs unvaccinatedRMST difference, days per decade (95% CI)
Vaccinated
95.14(94.99–95.30)

Observational data: associations, not effects.

Further findings

OutcomeHR (CI)
Specific CV outcomes — Vaccinated vs Unvaccinated · MACE0.74 (0.71–0.77)
Specific CV outcomes — Vaccinated vs Unvaccinated · HF0.74 (0.70–0.77)
Specific CV outcomes — Vaccinated vs Unvaccinated · cerebrovascular disorders0.76 (0.74–0.78)
Specific CV outcomes — Vaccinated vs Unvaccinated · ischaemic heart disease0.78 (0.76–0.80)
Specific CV outcomes — Vaccinated vs Unvaccinated · thrombotic disorders0.78 (0.74–0.83)
Specific CV outcomes — Vaccinated vs Unvaccinated · dysrhythmia0.79 (0.77–0.81)

Duration of association

Protective association persisted up to 8 years, greatest reduction 2-3 years post-vaccination

CVD risk by subgroup

Decrease more pronounced among males, age <60 years, unhealthy lifestyle habits, low-income households and rural residents

Original publication

Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study. Eur Heart J. Published 5 May 2025. doi:10.1093/eurheartj/ehaf230

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.